YS

Yogesh Subhash Sumbe

Active Director Director DIN 09106866
DIN 09106866 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2021
Shareholding value •••• Premium profile

About Yogesh Subhash Sumbe

Data last updated:

Yogesh Subhash Sumbe is a Director at Relez Pharma Private Limited (since 2021). The company operates in Pharma. Relez Pharma Private Limited reported revenue of ₹1.44 Cr (FY 2025).

DIN 09106866
Primary Designation Director
Industry Pharma
First Appointment 15 Mar 2021
Oldest Company Age 5 yrs
Largest company Relez Pharma Private Limited · ₹1.44 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Relez Pharma Private Limited U24290GJ2021PTC121177
Director15 Mar 20212021₹1.44 Cr (FY 2025)Active

Board colleagues of Yogesh Subhash Sumbe

Directorship timeline

Open interactive timeline →
Relez Pharma Private Limited
Premium access

Shareholding and investment profile for Yogesh Subhash Sumbe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogesh Subhash Sumbe

Yogesh Subhash Sumbe currently holds 1 directorship: Relez Pharma Private Limited (Director, since 15 Mar 2021, revenue ₹1.44 Cr (FY 2025)).

Yogesh Subhash Sumbe was first appointed on 15 Mar 2021 as Director at Relez Pharma Private Limited.

The current boards of Yogesh Subhash Sumbe's companies include Mayuri Bhausaheb Khevare (Relez Pharma Private Limited), Vivekananda Devi Potabattula (Relez Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available